DUBAI, United Arab Emirates--(BUSINESS WIRE)--May 13, 2015--Dubai Biotechnology and Research Park (DuBiotech), a free zone dedicated to facilitating and fostering growth in the UAE's life sciences industry, today announced that B.Braun, a German medical and pharmaceutical device firm, has established a Middle East operating subsidiary at the free zone business park.
During the ceremony (Photo: Business Wire)
B. Braun Medical Gulf will serve as a regional hub for its four divisions; B. Braun Hospital Care, B. Braun Aesculap, B. Braun OPM and B. Braun Avitum. From its new base at DuBiotech, B.Braun will now be able to offer a complete range of products and services for value retention of medical capital equipment, as well as provide planning and consulting services, training & education for the Gulf region.
B. Braun currently operates more than 50 companies around the world and is committed to increasing its global presence through organic growth.
Markus Strotmann, B.Braun CEO, commented: "One philosophy underpins everything we stand for at B.Braun and that is sharing expertise. This means that by sharing knowledge with our clients, B. Braun helps to improve therapies and procedures in hospitals and clinics to increase the safety of patients, doctors and nursing staff. This also helps drive innovation by exchanging knowledge with healthcare professionals and increasing efficiency with our expert employees worldwide."
" The Middle Eastern region has significant potential for developing a thriving health and life science sector. DuBiotech has established a vibrant community of like-minded life science professionals, which aids in the success of our objectives by providing health solutions. We're very excited to be part of this."
Marwan Abdulaziz, Executive Director of DuBiotech said: "The UAE's healthcare sector has substantial growth potential and as a result, Dubai is well placed to evolve into an innovative regional hub for R&D investment for major market players. The UAE has an open door policy to attract foreign investment, and together with the UAE Government, DuBiotech is working towards facilitating synergies that favour innovation, growth and development."
"Our aim is to develop relationships with the highest levels of Government and leading health industry representatives like B.Braun to drive the potential of the industry and ensure it is a major contributor to economic growth in the UAE."
For further information on DuBiotech, please visit our website: www.dubiotech.ae.
For further information on B.Barun, please visit www.bbraun.com.
Photos/Multimedia Gallery Available:http://www.businesswire.com/multimedia/home/20150513005371/en/
CONTACT: Bell Pottinger
Iain Munro, +971-55-559-7389
KEYWORD: UNITED ARAB EMIRATES CANADA MIDDLE EAST
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
Copyright Business Wire 2015
PUB: 05/13/2015 05:21 AM/DISC: 05/13/2015 05:21 AM